Your browser doesn't support javascript.
loading
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram, Mie Agermose; Emborg, Hanne-Dorthe; Schelde, Astrid Blicher; Friis, Nikolaj Ulrik; Nielsen, Katrine Finderup; Moustsen-Helms, Ida Rask; Legarth, Rebecca; Lam, Janni Uyen Hoa; Chaine, Manon; Malik, Aisha Zahoor; Rasmussen, Morten; Fonager, Jannik; Sieber, Raphael Niklaus; Stegger, Marc; Ethelberg, Steen; Valentiner-Branth, Palle; Hansen, Christian Holm.
Afiliación
  • Gram MA; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Schelde AB; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Friis NU; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Nielsen KF; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Moustsen-Helms IR; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Legarth R; Division of Infectious Disease Preparedness, Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
  • Lam JUH; Division of Infectious Disease Preparedness, Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
  • Chaine M; Division of Infectious Disease Preparedness, Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
  • Malik AZ; Division of Infectious Disease Preparedness, Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
  • Rasmussen M; Department of Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Fonager J; Department of Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Sieber RN; Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Stegger M; Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Ethelberg S; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Valentiner-Branth P; Department of Public Health, Global Health Section, University of Copenhagen, Copenhagen, Denmark.
  • Hansen CH; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
PLoS Med ; 19(9): e1003992, 2022 09.
Article en En | MEDLINE | ID: mdl-36048766
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Estados Unidos